Xtant Medical Holdings Inc (XTNT)
Official siteHEALTHCARE • MEDICAL DEVICES • AMEX
Market Cap: $38.12M
Last updated: Nov 17, 2026 at 11:05 AM ET
Xtant Medical Holdings Inc (XTNT) Stock Forecast
Analysts expect Xtant Medical Holdings (XTNT) to earn -$0.08 per share in the fiscal year ending Dec 31, 2026, on revenue of $99.44M. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.03.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 10.9%.
- Fiscal year ending Dec 31, 2026
- -$0.08
- EPS consensus, revenue $99.44M
- Fiscal year ending Dec 31, 2027
- -$0.03
- EPS consensus, revenue $110.23M
- Next report
- Mar 29, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.08 | -$0.08 to -$0.08 | 1 | $99.44M | $97.80M to $100.53M | 3 |
| Dec 31, 2027 | -$0.03 | -$0.06 to -$0.01 | 3 | $110.23M | $109.60M to $110.60M | 3 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.00 | -$0.01 to $0.00 | 5 | $28.83M | $24.78M to $31.50M | 5 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
EPS Trend
The EPS consensus for the fiscal year ending Dec 31, 2026 has held over the last 90 days.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.08 | N/A | -$0.08 | -$0.08 | -$0.08 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.03 | -$0.04 | -$0.01 | -$0.01 | -$0.01 | N/A |
Frequently Asked Questions About XTNT
What is the XTNT stock forecast?
Consensus analyst estimates put Xtant Medical Holdings's EPS at -$0.08 for the fiscal year ending Dec 31, 2026, on revenue of $99.44M.
What EPS do analysts expect from XTNT next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.08, with estimates from -$0.08 to -$0.08 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.03, with estimates from -$0.06 to -$0.01 from 3 analysts.
What revenue do analysts expect from Xtant Medical Holdings next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $99.44M, with estimates from $97.80M to $100.53M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $110.23M, with estimates from $109.60M to $110.60M.
How many analysts cover XTNT?
1 analyst estimates EPS for Xtant Medical Holdings for the fiscal year ending Dec 31, 2026.
XTNT pages: Overview, Earnings, Forecast, Financials, Competitors